Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infinite Potential Group is a venture studio and holding company dedicated to the longevity and human performance sectors. Founded by Dr. Peter Diamandis, the group focuses on incubating and scaling businesses that utilize exponential technologies to extend the healthy human lifespan. Its ecosystem includes high-profile ventures such as Fountain Life, which provides advanced diagnostics and longevity care, and Lifeforce, a personalized health platform. The group aims to shift the global healthcare focus from reactive sick-care to proactive, data-driven wellness and preventative medicine. By integrating artificial intelligence, whole genome sequencing, and advanced imaging, Infinite Potential Group seeks to democratize access to cutting-edge longevity interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infinite Potential Group.